APVO icon

Aptevo Therapeutics
APVO

Overview Fund Activity

8 hedge funds and large institutions have $5.99M invested in Aptevo Therapeutics in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SSA
1
Schonfeld Strategic Advisors
New York
$1.23M
2
Morgan Stanley
2
Morgan Stanley
New York
$883K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.77M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$364K

Top Sellers

1
TCM
1
Tang Capital Management
California
$0
2
RI
2
RTW Investments
New York
$0
3
TCM
3
Towercrest Capital Management
Pennsylvania
$0
4
Renaissance Technologies
4
Renaissance Technologies
New York
$541K
5
Franklin Resources
5
Franklin Resources
California
$123K
Name Holding Trade Value Shares
Change 		Shares
Change %
JC
26
JBF Capital
Colorado
– -$60K – –
1
2